Non-coding RNAs with essential roles in neurodegenerative disorders

The Lancet Neurology

Volumn 11, Issue 2, 2012, Pages 189-200

  Salta, Evgenia ^a,b   De Strooper, Bart ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ATAXIN 1; BETA SECRETASE 1; DNA DIRECTED RNA POLYMERASE III; MICRORNA; RNA POLYMERASE II; SMALL INTERFERING RNA; SMALL UNTRANSLATED RNA; UNTRANSLATED RNA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CAENORHABDITIS ELEGANS; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DISEASE COURSE; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; GENETIC CODE; HUMAN; HUNTINGTON CHOREA; LEWY BODY; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MYOTONIC DYSTROPHY; NONHUMAN; PARKINSON DISEASE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM; SPINAL MUSCULAR ATROPHY; TAUOPATHY; TRANSCRIPTION REGULATION;

ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; RNA, UNTRANSLATED;

EID: 84855991876     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70286-1     Document Type: Review

References (166)

1. Kapranov P, Cheng J, Dike S, et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316:1484-1488.
2. Berretta J, Morillon A Pervasive transcription constitutes a new level of eukaryotic genome regulation. EMBO Rep 2009, 10:973-982.
3. Brosius J Waste not, want not-transcript excess in multicellular eukaryotes. Trends Genet 2005, 21:287-288.
4. Mehler MF, Mattick JS Non-coding RNAs in the nervous system. J Physiol 2006, 575:333-341.
5. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci USA 2008, 105:716-721.
6. Kapsimali M, Kloosterman WP, de Bruijn E, Rosa F, Plasterk RH, Wilson SW MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol 2007, 8:R173.
7. Bak M, Silahtaroglu A, Moller M, et al. MicroRNA expression in the adult mouse central nervous system. RNA 2008, 14:432-444.
8. Cao X, Yeo G, Muotri AR, Kuwabara T, Gage FH Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci 2006, 29:77-103.
9. Mehler MF, Mattick JS Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev 2007, 87:799-823.
10. Mercer TR, Dinger ME, Mariani J, Kosik KS, Mehler MF, Mattick JS Noncoding RNAs in long-term memory formation. Neuroscientist 2008, 14:434-445.
11. Tsurudome K, Tsang K, Liao EH, et al. The Drosophila miR-310 cluster negatively regulates synaptic strength at the neuromuscular junction. Neuron 2010, 68:879-893.
12. Gao FB Context-dependent functions of specific microRNAs in neuronal development. Neural Dev 2010, 5:25.
13. Qureshi IA, Mehler MF Non-coding RNA networks underlying cognitive disorders across the lifespan. Trends Mol Med 2011, 17:337-346.
14. Siegel G, Saba R, Schratt G microRNAs in neurons: manifold regulatory roles at the synapse. Curr Opin Genet Dev 2011, 21:491-497.
15. St Laurent G, Faghihi MA, Wahlestedt C Non-coding RNA transcripts: sensors of neuronal stress, modulators of synaptic plasticity, and agents of change in the onset of Alzheimer's disease. Neurosci Lett 2009, 466:81-88.
16. Huarte M, Rinn JL Large non-coding RNAs: missing links in cancer?. Hum Mol Genet Oct 2010, 19:R152-R161.
17. Iorio MV, Croce CM MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009, 27:5848-5856.
18. Gibb EA, Brown CJ, Lam WL The functional role of long non-coding RNA in human carcinomas. Mol Cancer 2011, 10:38.
19. Tsai MC, Spitale RC, Chang HY Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 2011, 71:3-7.
20. Mattick JS The central role of RNA in human development and cognition. FEBS Lett 2011, 585:1600-1616.
21. Qureshi IA, Mattick JS, Mehler MF Long non-coding RNAs in nervous system function and disease. Brain Res 2010, 1338:20-35.
22. Werner A Natural antisense transcripts. RNA Biol 2005, 2:53-62.
23. Krol J, Loedige I, Filipowicz W The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610.
24. Carthew RW, Sontheimer EJ Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
25. Okamura K, Lai EC Endogenous small interfering RNAs in animals. Nat Rev Mol Cell Biol 2008, 9:673-678.
26. Thomson T, Lin H The biogenesis and function of PIWI proteins and piRNAs: progress and prospect. Annu Rev Cell Dev Biol 2009, 25:355-376.
27. Dieci G, Preti M, Montanini B Eukaryotic snoRNAs: a paradigm for gene expression flexibility. Genomics 2009, 94:83-88.
28. Valadkhan S snRNAs as the catalysts of pre-mRNA splicing. Curr Opin Chem Biol 2005, 9:603-608.
29. Taft RJ, Glazov EA, Cloonan N, et al. Tiny RNAs associated with transcription start sites in animals. Nat Genet 2009, 41:572-578.
30. Taft RJ, Simons C, Nahkuri S, et al. Nuclear-localized tiny RNAs are associated with transcription initiation and splice sites in metazoans. Nat Struct Mol Biol 2010, 17:1030-1034.
31. Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009, 458:223-227.
32. Werner A, Sayer JA Naturally occurring antisense RNA: function and mechanisms of action. Curr Opin Nephrol Hypertens 2009, 18:343-349.
33. Nakamori M, Thornton C Epigenetic changes and non-coding expanded repeats. Neurobiol Dis 2010, 39:21-27.
34. Furuno M, Pang KC, Ninomiya N, et al. Clusters of internally primed transcripts reveal novel long noncoding RNAs. PLoS Genet 2006, 2:e37.
35. Kim TK, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465:182-187.
36. Carninci P Constructing the landscape of the mammalian transcriptome. J Exp Biol 2007, 210:1497-1506.
37. Mattick JS The central role of RNA in the genetic programming of complex organisms. An Acad Bras Cienc 2010, 82:933-939.
38. Cheng J, Kapranov P, Drenkow J, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 2005, 308:1149-1154.
39. Lindberg J, Lundeberg J The plasticity of the mammalian transcriptome. Genomics 2010, 95:1-6.
40. Lee RC, Feinbaum RL, Ambros V The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
41. Saba R, Schratt GM MicroRNAs in neuronal development, function and dysfunction. Brain Res 2010, 1338:3-13.
42. Bartel DP MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
43. Vasudevan S, Tong Y, Steitz JA Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318:1931-1934.
44. Christensen M, Schratt GM microRNA involvement in developmental and functional aspects of the nervous system and in neurological diseases. Neurosci Lett 2009, 466:55-62.
45. Wayman GA, Davare M, Ando H, et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci USA 2008, 105:9093-9098.
46. Bernstein E, Kim SY, Carmell MA, et al. Dicer is essential for mouse development. Nat Genet 2003, 35:215-217.
47. Hebert SS, De Strooper B Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci 2009, 32:199-206.
48. Lukiw WJ Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 2007, 18:297-300.
49. Wang WX, Rajeev BW, Stromberg AJ, et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1. J Neurosci 2008, 28:1213-1223.
50. Hebert SS, Horre K, Nicolai L, et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression. Proc Natl Acad Sci USA 2008, 105:6415-6420.
51. Wang H, Liu J, Zong Y, et al. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor. Brain Res 2010, 1357:166-174.
52. Wang X, Liu P, Zhu H, et al. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull 2009, 80:268-273.
53. Smith P, Al Hashimi A, Girard J, Delay C, Hebert SS In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J Neurochem 2011, 116:240-247.
54. Sethi P, Lukiw WJ Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex. Neurosci Lett 2009, 459:100-104.
55. Kim J, Inoue K, Ishii J, et al. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224.
56. Miñones-Moyano E, Porta S, Escaramis G, et al. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet 2011, 20:3067-3078.
57. Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease. J Neurosci 2008, 28:14341-14346.
58. Marti E, Pantano L, Banez-Coronel M, et al. A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing. Nucleic Acids Res 2010, 38:7219-7235.
59. Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis 2008, 29:438-445.
60. Lee ST, Chu K, Im WS, et al. Altered microRNA regulation in Huntington's disease models. Exp Neurol 2011, 227:172-179.
61. Saba R, Goodman CD, Huzarewich RL, Robertson C, Booth SA A miRNA signature of prion induced neurodegeneration. PLoS One 2008, 3:e3652.
62. Montag J, Hitt R, Opitz L, Schulz-Schaeffer WJ, Hunsmann G, Motzkus D Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease. Mol Neurodegener 2009, 4:36.
63. Long JM, Lahiri DK MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. Biochem Biophys Res Commun 2011, 404:889-895.
64. Vilardo E, Barbato C, Ciotti M, Cogoni C, Ruberti F MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem 2010, 285:18344-18351.
65. Patel N, Hoang D, Miller N, et al. MicroRNAs can regulate human APP levels. Mol Neurodegener 2008, 3:10.
66. Niwa R, Zhou F, Li C, Slack FJ The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans. Dev Biol 2008, 315:418-425.
67. Boissonneault V, Plante I, Rivest S, Provost P MicroRNA-298 and microRNA-328 regulate expression of mouse β-amyloid precursor protein-converting enzyme 1. J Biol Chem 2009, 284:1971-1981.
68. Yang LB, Lindholm K, Yan R, et al. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 2003, 9:3-4.
69. Schonrock N, Ke YD, Humphreys D, et al. Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-β. PLoS One 2010, 5:e11070.
70. Hebert SS, Papadopoulou AS, Smith P, et al. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet 2010, 19:3959-3969.
71. Smith PY, Delay C, Girard J, et al. MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet 2011, 20:4016-4024.
72. Junn E, Lee KW, Jeong BS, Chan TW, Im JY, Mouradian MM Repression of α-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci USA 2009, 106:1305-1307.
73. Doxakis E Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem 2010, 285:12726-12734.
74. Wang G, van der Walt JM, Mayhew G, et al. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am J Hum Genet 2008, 82:283-289.
75. Gehrke S, Imai Y, Sokol N, Lu B Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 2010, 466:637-641.
76. Bilen J, Liu N, Burnett BG, Pittman RN, Bonini NM MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Mol Cell 2006, 24:157-163.
77. Lee Y, Samaco RC, Gatchel JR, Thaller C, Orr HT, Zoghbi HY miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat Neurosci 2008, 11:1137-1139.
78. Williams AH, Valdez G, Moresi V, et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326:1549-1554.
79. Rademakers R, Eriksen JL, Baker M, et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 2008, 17:3631-3642.
80. Haramati S, Chapnik E, Sztainberg Y, et al. miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci USA 2010, 107:13111-13116.
81. Perbellini R, Greco S, Sarra-Ferraris G, et al. Dysregulation and cellular mislocalization of specific miRNAs in myotonic dystrophy type 1. Neuromuscul Disord 2011, 21:81-88.
82. Aschrafi A, Schwechter AD, Mameza MG, Natera-Naranjo O, Gioio AE, Kaplan BB MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J Neurosci 2008, 28:12581-12590.
83. Ouyang YB, Lu Y, Yue S, Giffard RG miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion 2011, published online Sept 17. 10.1016/j.mito.2011.09.001.
84. Lukiw WJ, Zhao Y, Cui JG An NF-κB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 2008, 283:31315-31322.
85. Kocerha J, Faghihi MA, Lopez-Toledano MA, et al. MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci USA 2009, 106:3507-3512.
86. Glinsky GV SNP-guided microRNA maps (MirMaps) of 16 common human disorders identify a clinically accessible therapy reversing transcriptional aberrations of nuclear import and inflammasome pathways. Cell Cycle 2008, 7:3564-3576.
87. Saunders MA, Liang H, Li WH Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 2007, 104:3300-3305.
88. Richardson K, Lai CQ, Parnell LD, Lee YC, Ordovas JM A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS. BMC Genomics 2011, 12:504.
89. Mishra PJ, Bertino JR MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 2009, 10:399-416.
90. Zhang L, Liu Y, Song F, et al. Functional SNP in the microRNA-367 binding site in the 3' UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc Natl Acad Sci USA 2011, 108:13653-13658.
91. Mallick B, Ghosh Z A complex crosstalk between polymorphic microRNA target sites and AD prognosis. RNA Biol 2011, 8:665-673.
92. Delay C, Calon F, Mathews P, Hebert SS Alzheimer-specific variants in the 3'UTR of amyloid precursor protein affect microRNA function. Mol Neurodegener 2011, 6:70.
93. Dickson DW, Baker M, Rademakers R Common variant in GRN is a genetic risk factor for hippocampal sclerosis in the elderly. Neurodegener Dis 2010, 7:170-174.
94. de Mena L, Cardo LF, Coto E, et al. FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients. Neurosci Lett 2010, 479:22-25.
95. Prosser HM, Koike-Yusa H, Cooper JD, Law FC, Bradley A A resource of vectors and ES cells for targeted deletion of microRNAs in mice. Nat Biotechnol 2011, 29:840-845.
96. Smalheiser NR, Lugli G, Thimmapuram J, Cook EH, Larson J Endogenous siRNAs and noncoding RNA-derived small RNAs are expressed in adult mouse hippocampus and are up-regulated in olfactory discrimination training. RNA 2011, 17:166-181.
97. Matera AG, Terns RM, Terns MP Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs. Nat Rev Mol Cell Biol 2007, 8:209-220.
98. Zhang Z, Lotti F, Dittmar K, et al. SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 2008, 133:585-600.
99. Massone S, Vassallo I, Fiorino G, et al. 17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease. Neurobiol Dis 2011, 41:308-317.
100. Dharap A, Nakka VP, Vemuganti R Altered expression of PIWI RNA in the rat brain after transient focal ischemia. Stroke 2011, 42:1105-1109.
101. St Laurent G, Wahlestedt C Noncoding RNAs: couplers of analog and digital information in nervous system function?. Trends Neurosci 2007, 30:612-621.
102. DeChiara TM, Brosius J Neural BC1 RNA: cDNA clones reveal nonrepetitive sequence content. Proc Natl Acad Sci USA 1987, 84:2624-2628.
103. Tiedge H, Chen W, Brosius J Primary structure, neural-specific expression, and dendritic location of human BC200 RNA. J Neurosci 1993, 13:2382-2390.
104. Zhong J, Chuang SC, Bianchi R, et al. Regulatory BC1 RNA and the fragile X mental retardation protein: convergent functionality in brain. PLoS One 2010, 5:e15509.
105. Mus E, Hof PR, Tiedge H Dendritic BC200 RNA in aging and in Alzheimer's disease. Proc Natl Acad Sci USA 2007, 104:10679-10684.
106. Kuwabara T, Hsieh J, Nakashima K, Taira K, Gage FH A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell 2004, 116:779-793.
107. Pang KC, Frith MC, Mattick JS Rapid evolution of noncoding RNAs: lack of conservation does not mean lack of function. Trends Genet 2006, 22:1-5.
108. Ponting CP, Oliver PL, Reik W Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
109. Mercer TR, Qureshi IA, Gokhan S, et al. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neurosci 2010, 11:14.
110. Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci USA 2009, 106:11667-11672.
111. Zuccato C, Tartari M, Crotti A, et al. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 2003, 35:76-83.
112. Buckley NJ, Johnson R, Zuccato C, Bithell A, Cattaneo E The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease. Neurobiol Dis 2010, 39:28-39.
113. Osato N, Suzuki Y, Ikeo K, Gojobori T Transcriptional interferences in cis natural antisense transcripts of humans and mice. Genetics 2007, 176:1299-1306.
114. Li JT, Zhang Y, Kong L, Liu QR, Wei L Trans-natural antisense transcripts including noncoding RNAs in 10 species: implications for expression regulation. Nucleic Acids Res 2008, 36:4833-4844.
115. Faghihi MA, Wahlestedt C Regulatory roles of natural antisense transcripts. Nat Rev Mol Cell Biol 2009, 10:637-643.
116. Korneev S, O'Shea M Natural antisense RNAs in the nervous system. Rev Neurosci 2005, 16:213-222.
117. Pollard KS, Salama SR, Lambert N, et al. An RNA gene expressed during cortical development evolved rapidly in humans. Nature 2006, 443:167-172.
118. Tochitani S, Hayashizaki Y Nkx2.2 antisense RNA overexpression enhanced oligodendrocytic differentiation. Biochem Biophys Res Commun 2008, 372:691-696.
119. Okano H, Aruga J, Nakagawa T, Shiota C, Mikoshiba K Myelin basic protein gene and the function of antisense RNA in its repression in myelin-deficient mutant mouse. J Neurochem 1991, 56:560-567.
120. Ling KH, Hewitt CA, Beissbarth T, et al. Spatiotemporal regulation of multiple overlapping sense and novel natural antisense transcripts at the Nrgn and Camk2n1 gene loci during mouse cerebral corticogenesis. Cereb Cortex 2011, 21:683-697.
121. Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007, 90:397-406.
122. Korneev SA, Straub V, Kemenes I, et al. Timed and targeted differential regulation of nitric oxide synthase (NOS) and anti-NOS genes by reward conditioning leading to long-term memory formation. J Neurosci 2005, 25:1188-1192.
123. Faghihi MA, Modarresi F, Khalil AM, et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 2008, 14:723-730.
124. Faghihi MA, Zhang M, Huang J, et al. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 2010, 11:R56.
125. Parenti R, Paratore S, Torrisi A, Cavallaro S A natural antisense transcript against Rad18, specifically expressed in neurons and upregulated during β-amyloid-induced apoptosis. Eur J Neurosci 2007, 26:2444-2457.
126. Seitz A, Gourevitch D, Zhang XM, et al. Sense and antisense transcripts of the apolipoprotein E gene in normal and ApoE knockout mice, their expression after spinal cord injury and corresponding human transcripts. Hum Mol Genet 2005, 14:2661-2670.
127. Morais VA, Verstreken P, Roethig A, et al. Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 2009, 1:99-111.
128. Scheele C, Petrovic N, Faghihi MA, et al. The human PINK1 locus is regulated in vivo by a non-coding natural antisense RNA during modulation of mitochondrial function. BMC Genomics 2007, 8:74.
129. Chiba M, Kiyosawa H, Hiraiwa N, Ohkohchi N, Yasue H Existence of Pink1 antisense RNAs in mouse and their localization. Cytogenet Genome Res 2009, 126:259-270.
130. Johnson R, Richter N, Jauch R, et al. The human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease. Physiol Genomics 2010, published online Feb 23. 10.1152/physiolgenomics.00019.2010.
131. Orom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143:46-58.
132. Bond AM, Vangompel MJ, Sametsky EA, et al. Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat Neurosci 2009, 12:1020-1027.
133. Sopher BL, Ladd PD, Pineda VV, et al. CTCF regulates ataxin-7 expression through promotion of a convergently transcribed, antisense noncoding RNA. Neuron 2011, 70:1071-1084.
134. Koob MD, Moseley ML, Schut LJ, et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet 1999, 21:379-384.
135. Moseley ML, Zu T, Ikeda Y, et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 2006, 38:758-769.
136. Matsuura T, Yamagata T, Burgess DL, et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 2000, 26:191-194.
137. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 69:385.
138. Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
139. Holmes SE, O'Hearn E, Rosenblatt A, et al. A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease-like 2. Nat Genet 2001, 29:377-378.
140. Hagerman PJ, Hagerman RJ The fragile-X premutation: a maturing perspective. Am J Hum Genet 2004, 74:805-816.
141. Sone M, Hayashi T, Tarui H, Agata K, Takeichi M, Nakagawa S The mRNA-like noncoding RNA Gomafu constitutes a novel nuclear domain in a subset of neurons. J Cell Sci 2007, 120:2498-2506.
142. Komine Y, Tanaka NK, Yano R, et al. A novel type of non-coding RNA expressed in the rat brain. Brain Res Mol Brain Res 1999, 66:1-13.
143. Cavaille J, Vitali P, Basyuk E, Huttenhofer A, Bachellerie JP A novel brain-specific box C/D small nucleolar RNA processed from tandemly repeated introns of a noncoding RNA gene in rats. J Biol Chem 2001, 276:26374-26383.
144. French PJ, Bliss TV, O'Connor V Ntab, a novel non-coding RNA abundantly expressed in rat brain. Neuroscience 2001, 108:207-215.
145. Amaral PP, Neyt C, Wilkins SJ, et al. Complex architecture and regulated expression of the Sox2ot locus during vertebrate development. RNA 2009, 15:2013-2027.
146. Bernard D, Prasanth KV, Tripathi V, et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. EMBO J 2010, 29:3082-3093.
147. Tollervey JR, Curk T, Rogelj B, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 2011, 14:452-458.
148. Polymenidou M, Lagier-Tourenne C, Hutt KR, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 2011, 14:459-468.
149. Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008, 105:10513-10518.
150. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3:e3694.
151. Baraniskin A, Kuhnhenn J, Schlegel U, et al. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system. Blood 2011, 117:3140-3146.
152. Kosaka N, Iguchi H, Ochiya T Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010, 101:2087-2092.
153. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011, 108:5003-5008.
154. Cogswell JP, Ward J, Taylor IA, et al. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008, 14:27-41.
155. Schwarzenbach H, Hoon DS, Pantel K Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011, 11:426-437.
156. Edwards JK, Pasqualini R, Arap W, Calin GA MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases. J Cardiovasc Transl Res 2010, 3:271-279.
157. Cooper TA, Wan L, Dreyfuss G RNA and disease. Cell 2009, 136:777-793.
158. Weinberg MS, Wood MJ Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics. Hum Mol Genet 2009, 18:R27-R39.
159. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
160. Wang Z, Rao DD, Senzer N, Nemunaitis J RNA interference and cancer therapy. Pharm Res 2011, published online Oct 19. 10.1007/s11095-011-0604-5.
161. Poller W, Fechner H Development of novel cardiovascular therapeutics from small regulatory RNA molecules-an outline of key requirements. Curr Pharm Des 2010, 16:2252-2268.
162. Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 2011, 11:59-67.
163. Kumar P, Wu H, McBride JL, et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448:39-43.
164. Ehlert EM, Eggers R, Niclou SP, Verhaagen J Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system. BMC Neurosci 2010, 11:20.
165. Martin JN, Wolken N, Brown T, Dauer WT, Ehrlich ME, Gonzalez-Alegre P Lethal toxicity caused by expression of shRNA in the mouse striatum: implications for therapeutic design. Gene Ther 2011, 18:666-673.
166. Jackson AL, Linsley PS Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov 2010, 9:57-67.